Pfizer Inc. (PFE)
Pfizer upgrades guidance; on track to deliver $4bn of net cost savings
Pfizer Inc's (NYSE:PFE, ETR:PFE) stock is up ahead of the bell after the company raised its annual profit forecast following stronger-than-expected sales of its Covid vaccine and antiviral treatment. The drugmaker now anticipates an annual profit of $2.45 to $2.65 per share, up from its previous forecast of $2.15 to $2.35 per share.
Pfizer Beats Q2 Estimates, Boosts 2024 Outlook
Pfizer's Q2 revenue reaches $13.28 billion, marking a 2% increase year-over-year and surpassing projected $12.96 billion
Pfizer Stock Rises On Earnings Beat, Raised Outlook
Pfizer beat second-quarter views and guided up for the full year. Pfizer stock, already in a buy zone, rose Tuesday.
Pfizer beats earnings estimates, hikes full-year outlook as drugmaker cuts costs
Pfizer reported second-quarter revenue and adjusted earnings that blew past expectations and raised its full-year outlook as the drugmaker works to slash costs. The results come as Pfizer scrambles to stabilize its business and win back Wall Street's favor following the rapid decline in demand for its Covid products.
Pfizer raises annual profit forecast after better-than-expected COVID sales
U.S. drugmaker Pfizer on Tuesday raised its annual profit forecast after reporting better-than-expected sales of its COVID vaccine and antiviral treatment.
Pfizer Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Pfizer Inc. PFE is scheduled to release its financial results for the second quarter, before the opening bell on Tuesday.
How To Earn $500 A Month From Pfizer Stock Ahead Of Q2 Earnings
Pfizer Inc. PFE will release its financial results for the second quarter, before the opening bell on Tuesday.
Prediction: This Will Be Pfizer's Next Big Move
Pfizer is in the midst of a strategic transition to new sources of revenue. It has enough capital to ease that transition by making acquisitions.
Pfizer And Merck's Earnings Previews: Uncorrelated To Big Tech, And Growth Styles
Both Merck and Pfizer are expected to report their Q2 '24 financial results on Tuesday morning, July 30 '24, before the opening bell. It's time for Pfizer to make hay after the pandemic spike, when the stock jumped from $30 in 2020 to $60 in late '21. Today, Merck is really all about Keytruda and what the pharma giant can squeeze from it, as it awaits further pipeline development.
High Yielding Pfizer Looks Bullish (Technical Analysis)
Pfizer yields 5.57% with a B- dividend safety rating, known for Eliquis and Xeljanz. Technical analysis tools show bullish trends: trading above 30-week EMA, increasing momentum, and improving relative strength. Smart money buying, volume spikes, and breakout from consolidation suggest bullish outlook for Pfizer stock.
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know
Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Will Pfizer Stock Post A Downbeat Q2?
Pfizer (NYSE: PFE) is scheduled to report its Q2 2024 results on Tuesday, July 30. We expect the company to post revenue of $12.95 billion and earnings of $0.44 on a per share and adjusted basis, lower than the consensus estimates.
